Balance Sheet - Edgewise Therapeutics, Inc. (EWTX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 530.11 | 470.17 | 318.39 | 351.95 | 280.79 | 129.09 | 23.65 |
| Accounts receivable, net | 0.25 | 0.55 | |||||
| Other current assets | 13.28 | 5.31 | 8.60 | 5.05 | 2.98 | 0.55 | 0.39 |
| Total current assets | 543.39 | 475.48 | 327.00 | 357.00 | 283.77 | 129.65 | 24.04 |
| Total non-current assets | 9.22 | 11.33 | 13.04 | 10.10 | 1.46 | 1.49 | 0.50 |
| Total assets | 552.60 | 486.82 | 340.04 | 367.10 | 285.23 | 131.14 | 24.54 |
| Total current liabilities | 27.37 | 23.86 | 16.77 | 16.59 | 10.52 | 4.34 | 1.13 |
| Total non-current liabilities | 2.98 | 3.74 | 4.43 | 3.80 | 0.33 | 160.21 | 40.26 |
| Total liabilities | 30.35 | 27.60 | 21.21 | 20.39 | 10.85 | 164.56 | 41.39 |
| Total stockholders' equity | 522.26 | 459.22 | 318.83 | 346.72 | 274.38 | -33.42 | -16.85 |
| Common shares outstanding | 103 | 92 | 64 | 54 | 50 | 49 | 49 |
Show Quarterly Balance Sheet
Balance Sheet - Edgewise Therapeutics, Inc. (EWTX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 499.56 | 530.11 | 563.34 | 593.99 | 436.39 | 470.17 | 492.54 | 511.75 | 532.76 | 318.39 | 289.70 | 309.93 | 327.95 | 351.95 | 364.82 | 248.40 | 265.83 | 280.79 | 290.48 | 299.15 | 309.87 | 129.09 | 0.00 | 0.00 | 23.65 |
| Accounts receivable, net | 0.42 | 0.25 | 0.25 | 0.26 | 0.45 | 0.56 | 0.55 | 0.30 | 0.20 | ||||||||||||||||
| Other current assets | 10.23 | 13.28 | 10.56 | 9.26 | 6.79 | 5.31 | 6.90 | 7.69 | 8.67 | 8.60 | 8.22 | 7.07 | 5.41 | 5.05 | 5.32 | 4.95 | 2.78 | 2.98 | 2.76 | 3.82 | 0.67 | 0.55 | |||
| Total current assets | 509.79 | 543.39 | 573.90 | 603.26 | 443.18 | 475.48 | 499.44 | 519.44 | 541.43 | 327.00 | 297.92 | 317.00 | 333.36 | 357.00 | 370.14 | 253.34 | 268.62 | 283.77 | 293.24 | 302.97 | 310.55 | 129.65 | 23.65 | ||
| Total non-current assets | 8.73 | 9.22 | 9.57 | 10.08 | 11.21 | 11.33 | 11.85 | 12.21 | 12.38 | 13.04 | 13.44 | 13.63 | 13.04 | 10.10 | 7.01 | 4.06 | 4.13 | 1.46 | 1.21 | 0.52 | 0.70 | 1.49 | -23.65 | ||
| Total assets | 518.52 | 552.60 | 583.47 | 613.33 | 454.39 | 486.82 | 511.28 | 531.65 | 553.81 | 340.04 | 311.36 | 330.63 | 346.40 | 367.10 | 377.15 | 257.40 | 272.75 | 285.23 | 294.45 | 303.49 | 311.25 | 131.14 | |||
| Total current liabilities | 22.54 | 27.37 | 21.65 | 20.90 | 21.12 | 23.86 | 18.96 | 17.18 | 14.60 | 16.77 | 16.34 | 14.40 | 12.72 | 16.59 | 13.30 | 9.22 | 10.00 | 10.52 | 8.75 | 6.74 | 4.85 | 4.34 | |||
| Total non-current liabilities | 2.78 | 2.98 | 3.17 | 3.37 | 3.56 | 3.74 | 3.45 | 4.00 | 4.27 | 4.43 | 4.60 | 4.77 | 4.85 | 3.80 | 2.45 | 1.83 | 2.39 | 0.33 | 0.30 | 0.00 | 0.00 | 160.21 | |||
| Total liabilities | 25.32 | 30.35 | 24.82 | 24.26 | 24.67 | 27.60 | 22.41 | 21.17 | 18.87 | 21.21 | 20.94 | 19.17 | 17.56 | 20.39 | 15.75 | 11.04 | 12.39 | 10.85 | 9.05 | 6.74 | 4.85 | 164.56 | |||
| Total stockholders' equity | 493.20 | 522.26 | 558.65 | 589.07 | 429.72 | 459.22 | 488.88 | 510.47 | 534.94 | 318.83 | 290.43 | 311.46 | 328.84 | 346.72 | 361.40 | 246.36 | 260.36 | 274.38 | 285.40 | 296.75 | 306.39 | -33.42 | 23.41 | ||
| Common shares outstanding | 107 | 103 | 105 | 105 | 95 | 92 | 94 | 94 | 88 | 65 | 63 | 63 | 63 | 63 | 52 | 50 | 50 | 49 | 49 | 49 | 49 | 20 | 20 | 20 | 20 |